Accounting for the Drug Life Cycle and Future Drug Prices in Cost-Effectiveness Analysis

By Hoyle Martin  

PharmacoEconomics, Vol. 29, Iss. 1, 2011-01 ,pp. : 1-15

Adis International

Access to resources Recommend Favorite

The Economic Impact of Introducing Serotonin-Noradrenaline Reuptake Inhibitors into the Brazilian National Drug Formulary: Cost-Effectiveness and Budget-Impact Analyses

By Machado Márcio   Iskedjian Michael  

PharmacoEconomics, Vol. 25, Iss. 11, 2007-01 ,pp. : 979-990

Adis International

Access to resources Recommend Favorite

A systematic review of cost-effectiveness analyses of pharmacogenomic interventions

By Phillips Kathryn A   Van Bebber Stephanie L  

Pharmacogenomics, Vol. 5, Iss. 8, 2004-12 ,pp. : 1139-1149

Future Medicine

Access to resources Recommend Favorite

The Importance of Cost Inputs and Sensitivity Analyses in a Cost-Effectiveness Analysis

By PharmD Jenna L. Yoder  

Clinical Drug Investigation, Vol. 28, Iss. 7, 2008-01 ,pp. : 461-462

Adis International

Access to resources Recommend Favorite

Review of cost-effectiveness analyses in hormonal therapies in advanced breast cancer

By Benedict Ágnes   Brown Ruth E  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 11, 2005-09 ,pp. : 1789-1801

Informa Healthcare

Access to resources Recommend Favorite